162 related articles for article (PubMed ID: 21239758)
1. Use of serum clara cell 16-kDa (CC16) levels as a potential indicator of active pulmonary fibrosis in systemic sclerosis.
Hasegawa M; Fujimoto M; Hamaguchi Y; Matsushita T; Inoue K; Sato S; Takehara K
J Rheumatol; 2011 May; 38(5):877-84. PubMed ID: 21239758
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Asano Y; Ihn H; Yamane K; Yazawa N; Kubo M; Fujimoto M; Tamaki K
Arthritis Rheum; 2001 Jun; 44(6):1363-9. PubMed ID: 11407696
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
[TBL] [Abstract][Full Text] [Related]
4. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
Hara T; Ogawa F; Yanaba K; Iwata Y; Muroi E; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement.
Bonella F; Volpe A; Caramaschi P; Nava C; Ferrari P; Schenk K; Ohshimo S; Costabel U; Ferrari M
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):27-33. PubMed ID: 21796888
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Values For Club Cell Secretory Protein (CC16) in Serum of Patients of Combined Pulmonary Fibrosis and Emphysema.
Kokuho N; Ishii T; Kamio K; Hayashi H; Kurahara M; Hattori K; Motegi T; Azuma A; Gemma A; Kida K
COPD; 2015 Aug; 12(4):347-54. PubMed ID: 25244495
[TBL] [Abstract][Full Text] [Related]
11. Elevated circulating TWEAK levels in systemic sclerosis: association with lower frequency of pulmonary fibrosis.
Yanaba K; Yoshizaki A; Muroi E; Hara T; Ogawa F; Usui A; Hasegawa M; Fujimoto M; Takehara K; Sato S
J Rheumatol; 2009 Aug; 36(8):1657-62. PubMed ID: 19531747
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Yanaba K; Komura K; Kodera M; Matsushita T; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
[TBL] [Abstract][Full Text] [Related]
13. [Serum biomarkers in idiopathic pulmonary fibrosis].
Chudzicka A
Pol Merkur Lekarski; 2010 Nov; 29(173):291-5. PubMed ID: 21268912
[TBL] [Abstract][Full Text] [Related]
14. Lung epithelium injury biomarkers in workers exposed to sulphur dioxide in a non-ferrous smelter.
Haddam N; Samira S; Dumont X; Taleb A; Haufroid V; Lison D; Bernard A
Biomarkers; 2009 Aug; 14(5):292-8. PubMed ID: 19552616
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.
Hant FN; Ludwicka-Bradley A; Wang HJ; Li N; Elashoff R; Tashkin DP; Silver RM;
J Rheumatol; 2009 Apr; 36(4):773-80. PubMed ID: 19286849
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of Clara cell protein 16 but not surfactant protein D identify and quantify lung damage in patients with multiple injuries.
Wutzler S; Lehnert T; Laurer H; Lehnert M; Becker M; Henrich D; Vogl T; Marzi I
J Trauma; 2011 Aug; 71(2):E31-6. PubMed ID: 21045740
[TBL] [Abstract][Full Text] [Related]
17. [Changes of Clara cell protein and surfactant protein-D in serum of patients with silicosis].
Liu P; Wang SX; Chen L; Wei MT; Liang XC; Wang YF; Tu ZG
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2007 Jan; 25(1):18-21. PubMed ID: 17374182
[TBL] [Abstract][Full Text] [Related]
18. [Serum biomarkers in idiopathic pulmonary fibrosis].
Ziora D
Pneumonol Alergol Pol; 2007; 75(3):268-72. PubMed ID: 17966103
[TBL] [Abstract][Full Text] [Related]
19. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study.
Determann RM; Millo JL; Waddy S; Lutter R; Garrard CS; Schultz MJ
BMC Pulm Med; 2009 Dec; 9():49. PubMed ID: 19958527
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction?
Vancheeswaran R; Magoulas T; Efrat G; Wheeler-Jones C; Olsen I; Penny R; Black CM
J Rheumatol; 1994 Oct; 21(10):1838-44. PubMed ID: 7837147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
